- Home
- PLUR vs PYPD Comparison
PLUR vs PYPD Comparison
Compare PLUR & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- PYPD
- Stock Information
- Founded
- PLUR 2001
- PYPD 2008
- Country
- PLUR Israel
- PYPD Israel
- Employees
- PLUR N/A
- PYPD 61
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- PYPD Medical/Dental Instruments
- Sector
- PLUR Health Care
- PYPD Health Care
- Exchange
- PLUR Nasdaq
- PYPD Nasdaq
- Market Cap
- PLUR 41.9M
- PYPD 36.0M
- IPO Year
- PLUR N/A
- PYPD 2020
- Fundamental
- Price
- PLUR $5.88
- PYPD $3.50
- Analyst Decision
- PLUR Strong Buy
- PYPD Strong Buy
- Analyst Count
- PLUR 1
- PYPD 5
- Target Price
- PLUR $12.00
- PYPD $11.40
- AVG Volume (30 Days)
- PLUR 62.9K
- PYPD 1.4M
- Earning Date
- PLUR 05-13-2025
- PYPD 08-13-2025
- Dividend Yield
- PLUR N/A
- PYPD N/A
- EPS Growth
- PLUR N/A
- PYPD N/A
- EPS
- PLUR N/A
- PYPD N/A
- Revenue
- PLUR $1,034,000.00
- PYPD N/A
- Revenue This Year
- PLUR $472.39
- PYPD N/A
- Revenue Next Year
- PLUR $254.29
- PYPD N/A
- P/E Ratio
- PLUR N/A
- PYPD N/A
- Revenue Growth
- PLUR 203.23
- PYPD N/A
- 52 Week Low
- PLUR $3.33
- PYPD $2.30
- 52 Week High
- PLUR $7.13
- PYPD $4.42
- Technical
- Relative Strength Index (RSI)
- PLUR 66.26
- PYPD 56.01
- Support Level
- PLUR $4.61
- PYPD $3.42
- Resistance Level
- PLUR $5.40
- PYPD $3.62
- Average True Range (ATR)
- PLUR 0.55
- PYPD 0.18
- MACD
- PLUR 0.13
- PYPD -0.03
- Stochastic Oscillator
- PLUR 91.46
- PYPD 60.51
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.